⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

PFE

Pfizer Inc.

Healthcare · Drug Manufacturers - General

27.78USD

-0.0100 (-0.04%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 27.78
P/E36.6
Dvd Ind Yld6.1%
P/B1.86
P/S2.5
Curr EV/T12M EBITDA8.4
Mkt Cap (USD)158.4B
Curr EV (USD)214.2B
2)

Per Share Data

EPS T12M0.76
DPS1.72
Bk Val Per Sh14.95
Rev/Sh11.18
Cash/Sh2.05
Curr Shares Out5,699.7M
FCF/Sh1.93
3)

Cash Flow Analysis

P/CF11.8
Curr P/FCF14.4
CF/NI3.1
Dvd P/O226.3%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales21.0%
Eff Interest Rate4.3%
4)

Growth Potential

Dil EPS 1Y Gr-3.5%
Cap 1Y Gr-0.8%
BPS 1Y Gr-2.2%
R&D To Sales—
Retention Rate-126.3%
Rev 1Y Gr-1.6%
FCF 1Y Gr-7.7%
Assets 1Y Gr-2.5%
5)

Profitability

EBITDA25.4B
EBIT—
Operating Margin27.9%
Pretax Margin6.6%
Net Margin6.8%
ROA2.1%
ROE5.0%
ROC—
Asset Turnover0.31
6)

Structure

Current Ratio1.27
Quick Ratio0.85
Debt/Assets31.4%
Debt/Com Eq74.2%
Net Debt/EBITDA2.45
Tot Debt/Capital42.6%
Gross Margin73.2%
EBIT/Int Exp—

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.